Skip to Content

AP207 (Alendronate sodium 35 mg)

Pill imprint AP207 has been identified as Alendronate sodium 35 mg.

Alendronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not a controlled substance under the Controlled Substance Act (CSA).

Alendronate sodium 35 mg AP207
Alendronate sodium 35 mg AP207
Alendronate sodium 35 mg AP207
Alendronate sodium
Imprint:
AP207
Strength:
35 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Ascend Laboratories, LLC
National Drug Code (NDC):
67877-0240
Inactive Ingredients:
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
24658-0162 Blu Pharmaceuticals LLC

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide